Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01498549 · ClinicalTrials.gov registry record · NA
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
A NA study of Addiction, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT01498549: Completed NA study of Addiction, sponsored by Yale University.
NCT01498549 is a NA study of Addiction that has completed, run by Yale University. The registered enrollment target is 35 participants, below the 691-participant average among 16 other Addiction trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01498549, a NA study of Addiction, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects of atomoxetine.
Primary Outcome
Cognitive Test to determine the speed of Visual information. The CANTAB Rapid Visual Information Processing test (RVP) is a measure of sustained attention with a small working memory component (Sahakian and Owen, 1992). Digits are rapidly (100/minute) and pseudo-randomly presented for 7 minutes. Subjects are instructed to press when the third digit of a target sequence (e.g. 3-5-7) is displayed. Primary outcomes are indices of target discriminability (A') and response bias (B") and response late
Conditions Studied
Interventions
- DRUG Atomoxetine
- DRUG Sugar Pill
Study Locations (1)
Connecticut
- Department of Veterans Affairs - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01498549 record still lists
NCT01498549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 691-participant average among 16 other Addiction trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Addiction appearing as the primary indexed condition, and to 2 interventions - of which Atomoxetine is the first listed.
NCT01498549 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01498549 about?
NCT01498549 is a clinical study titled "Cognitive Effects of Atomoxetine in Humans: Genetic Moderators". The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects ...
What is the current status of trial NCT01498549?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2011-12. Estimated completion is 2013-07.
What conditions does trial NCT01498549 study?
This clinical trial studies the following conditions: Addiction.
What interventions are being tested in trial NCT01498549?
The interventions under investigation include: Atomoxetine (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT01498549?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01498549 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01498549's enrollment target sits among peer trials
35 13th of 16 higher than 4 of 16 other Addiction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
RECRUITING · NA
-
Behavioral and Functional Task Development, Implementation, and Testing
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
ACTIVE NOT RECRUITING · NA
-
Group Activities to Support Addiction Recovery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia